CAR T-cell therapy could be made in the body of someone with cancer
Illustration of CAR T-cell therapy targeting multiple myeloma, a type of blood cancer Nemes Laszlo/Alamy CAR T-cell therapy has the potential to revolutionise how we treat certain types of cancer by genetically engineering someone’s own immune cells to attack the disease – but it is also cumbersome and expensive. Now, scientists have managed to create…
